A Prospective, Randomized Trial Comparing the Outcomes of Open vs Laparoscopic Partial Nephrectomy

Purpose: Partial nephrectomy is the standard treatment for renal tumors <7 cm, and the trend toward minimally invasive surgery has increased. However, data that could support its use and benefits are still lacking. Materials and Methods: We conducted a prospective, randomized controlled trial comparing surgical, functional and oncologic outcomes in patients undergoing open partial nephrectomy (OPN) or laparoscopic partial nephrectomy (LPN). Randomization was 1:1 to OPN or LPN for the treatment of renal tumors <7 cm. The primary endpoint was surgical complications up to 90 days after surgery. Secondary outcomes were comparison of surgical, oncologic and functional results. Results: We randomized 208 patients between 2012 and 2020 (110 with OPN vs 98 with LPN). Operative data showed no differences in operative time, warm ischemia time, estimated blood loss, transfusions or length of hospital stay. Zero ischemia was more frequent in the OPN (35.4% vs 15.5%, p=0.02). OPN was associated with more abdominal wall complications (31.2% vs 13.1%, p=0.004). Regarding oncologic outcomes, no differences were noted. The LPN group had less kidney function reduction at 3 (-5.2% vs -10%, p=0.04; CI 0.09 to 9.46) and 12 months after surgery (-0.8% vs -6.3%, p=0.02; CI 1.18 to 12.95), and a lower rate of downstaging on the chronic kidney disease classification at 12 months (14.1% vs 32.6%, p=0.006). Conclusions: Surgical and oncologic outcomes of LPN were similar to OPN. Minimally invasive surgery may provide better preservation of kidney function. More studies, especially those involving robotic surgery, are necessary to confirm our findings.

Palavras-chave

kidney neoplasms, prospective studies, laparoscopy

URI

https://observatorio.fm.usp.br/handle/OPI/48215

Referências

Altunrende F, 2011, J UROLOGY, V186, P35, DOI 10.1016/j.juro.2011.03.024
Chang KD, 2018, BJU INT, V122, P618, DOI 10.1111/bju.14250
Chang XF, 2015, J UROLOGY, V193, P430, DOI 10.1016/j.juro.2014.07.112
CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
Chen FM, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000013927
Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
Ebbing J, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1215-3
Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038
Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
Greco F, 2019, EUR UROL, V75, P477, DOI 10.1016/j.eururo.2018.10.005
Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005
Marszalek M, 2009, EUR UROL, V55, P1171, DOI 10.1016/j.eururo.2009.01.042
Pereira J, 2018, J ENDOUROL, V32, P116, DOI 10.1089/end.2017.0609
Porpiglia F, 2016, UROLOGY, V89, P45, DOI 10.1016/j.urology.2015.08.049
Medeiros FSR, 2009, TRANSPL INT, V22, P323, DOI 10.1111/j.1432-2277.2008.00799.x
Riggs SB, 2008, CANCER J, V14, P302, DOI 10.1097/PPO.0b013e31818675ae
Soveri I, 2014, AM J KIDNEY DIS, V64, P411, DOI 10.1053/j.ajkd.2014.04.010
Thompson RH, 2010, EUR UROL, V58, P340, DOI 10.1016/j.eururo.2010.05.047
Xia LL, 2019, UROL ONCOL-SEMIN ORI, V37, DOI 10.1016/j.urolonc.2018.10.028
You CY, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.583979
Zini L, 2009, CANCER-AM CANCER SOC, V115, P1465, DOI 10.1002/cncr.24035

Coleções

Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/55
Artigos e Materiais de Revistas Científicas - ODS/03

Página do item completo